Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Gilead Sciences
Age
12–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Males and Females between 12 and 75 years of age
Current diagnosis of IPAH, FPAH, or PAH associated with collagen vascular disease, congenital systemic-to-pulmonary shunts, anorexigen use, HIV infection
Must have previously discontinued bosentan or sitaxsentan therapy due to serum aminotransferase (ALT and/or AST) concentrations \> 3 x ULN
Must have normal (\< 1 x ULN) serum ALT and AST concentrations at screening
Six-minute Walk distance of at least 150 meters at screening
If receiving sildenafil or a clinically approved prostanoid for PAH, must have been on stable therapy for at least 4 weeks prior to screening
Subjects with a diagnosis of HIV must have stable disease status during the screening period
